Mostrar el registro sencillo del ítem
dc.contributor.author | Ochoa Woodell, Theresa Jean | |
dc.contributor.author | Pezo, Alonso | |
dc.contributor.author | Cruz, Karen | |
dc.contributor.author | Chea-Woo, Elsa | |
dc.contributor.author | Cleary, Thomas G. | |
dc.date.accessioned | 2022-01-18T19:34:34Z | |
dc.date.available | 2022-01-18T19:34:34Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/11013 | |
dc.description.abstract | Much has been learned in recent years about the mechanisms by which breastfeeding improves child health and survival. However, there has been little progress in using these insights to improve pediatric care. The aim of this study was to review all clinical studies of lactoferrin (LF) in children in an effort to determine which interventions may improve pediatric care or require further research. We conducted a systematic and critical review of published literature and found 19 clinical studies that have used human or bovine LF for different outcomes: iron metabolisms and anemia (6 studies), fecal flora (5 studies), enteric infections (3 studies), common pediatric illnesses (1 study), immunomodulation (3 studies), and neonatal sepsis (1 study). Although the efficacies have varied in each trial, the main finding of all published studies is the safety of the intervention. Protection against enteric infections and neonatal sepsis are the most likely biologically relevant activities of LF in children. Future studies on neonatal sepsis should answer critically important questions. If the data from these sepsis studies are proven to be correct, it will profoundly affect the treatment of low birth weight neonates and will aid in the reduction of child mortality worldwide. | en_US |
dc.description.abstract | Au cours des dernières années, on en a appris beaucoup sur les mécanismes par lesquels l’allaitement améliore la santé et la survie de l’enfant. Cependant, il y a eu peu de progrès quant à l’utilisation de ces connaissances pour améliorer les soins pédiatriques. Cette étude vise à passer en revue toutes les études cliniques portant sur la lactoferrine chez les enfants, afin de déterminer quelles sont les interventions qui peuvent améliorer les soins pédiatriques ou nécessitent des recherches plus approfondies. Nous avons réalisé une revue systématique et critique de la littérature publiée et nous avons trouvé 19 études cliniques dans lesquelles la lactoferrine bovine ou humaine avait été utilisée à différentes fins : le métabolisme du fer et l’anémie (6 études), la flore fécale (5 études), les infections entériques (3 études), les maladies pédiatriques courantes (1 étude), l’immunomodulation (3 études) et la sepsie néonatale (1 étude). Malgré une efficacité variable selon les essais, la principale conclusion tirée de toutes ces études publiées était la sécurité de l’intervention. La protection contre les infections entériques et la sepsie néonatale constituent probablement les activités les plus pertinentes biologiquement de la lactoferrine chez les enfants. Si les données découlant des études portant sur la sepsie s’avèrent justes, cela affectera profondément le traitement des nouveaux-nés de faible poids et contribuera à la réduction de la mortalité infantile dans le monde. | fr_FR |
dc.language.iso | eng | |
dc.publisher | NRC Research Press | |
dc.relation.ispartofseries | Biochemistry and Cell Biology | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Humans | en_US |
dc.subject | placebo | en_US |
dc.subject | Infant, Newborn | en_US |
dc.subject | Feces | en_US |
dc.subject | Clinical trial | en_US |
dc.subject | birth weight | en_US |
dc.subject | treatment outcome | en_US |
dc.subject | childhood disease | en_US |
dc.subject | anemia | en_US |
dc.subject | systematic review | en_US |
dc.subject | intestine infection | en_US |
dc.subject | Bovinae | en_US |
dc.subject | Lactoferrin | en_US |
dc.subject | Biochemistry | en_US |
dc.subject | Breastfeeding | en_US |
dc.subject | Cell culture | en_US |
dc.subject | child care | en_US |
dc.subject | Child Health Services | en_US |
dc.subject | Child mortality | en_US |
dc.subject | Children | en_US |
dc.subject | Clinical studies|Clinical Trials as Topic | en_US |
dc.subject | Communicable Diseases | en_US |
dc.subject | Critical review | en_US |
dc.subject | feces microflora | en_US |
dc.subject | Gastrointestinal Diseases | en_US |
dc.subject | Immunomodulation | en_US |
dc.subject | Iron metabolism | en_US |
dc.subject | Iron Metabolism Disorders | en_US |
dc.subject | Low birth weights | en_US |
dc.subject | newborn sepsis | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Sepsis | en_US |
dc.title | Clinical studies of lactoferrin in children | en_US |
dc.type | info:eu-repo/semantics/review | |
dc.identifier.doi | https://doi.org/10.1139/o11-087 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#1.06.03 | |
dc.relation.issn | 1208-6002 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |